These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 17224011)
1. The Diamed assay has a poor positive predictive value for HIT in a tertiary hospital referral setting. Alhaliq AR; Joshua D; Kershaw G; Dunkley S Int J Lab Hematol; 2007 Feb; 29(1):69-70. PubMed ID: 17224011 [No Abstract] [Full Text] [Related]
8. Significance of quantitative measurement of heparin-induced platelet antibodies. Javela K; Kekomäki R; Koskinen S Eur J Haematol; 2010 Feb; 84(2):169-74. PubMed ID: 19845741 [TBL] [Abstract][Full Text] [Related]
9. Urgent cardiac surgery in a patient with a remote history of heparin-induced thrombocytopenia: use of the anti-PF4/heparin ELISA confirmatory test. Dellaria SM; Greilich PE; Sarode R Anesth Analg; 2008 Aug; 107(2):379-81. PubMed ID: 18633011 [TBL] [Abstract][Full Text] [Related]
10. A modified PF4-dependent, CD62p expression assay selectively detects serotonin-releasing antibodies in patients suspected of HIT. Padmanabhan A; Jones CG; Bougie DW; Curtis BR; McFarland JG; Wang D; Aster RH Thromb Haemost; 2015 Nov; 114(6):1322-3. PubMed ID: 26177881 [No Abstract] [Full Text] [Related]
11. An update on the prevalence and characterization of H-PF4 antibodies in Asian-Indian patients. Kannan M; Saxena R; Adiguzel C; Fareed J Semin Thromb Hemost; 2009 Apr; 35(3):337-43. PubMed ID: 19452409 [TBL] [Abstract][Full Text] [Related]
12. Frequency of anti-heparin-PF4 complex antibodies (HIT antibodies) in uremic patients on chronic intermittent hemodialysis. Matsuo T; Kobayashi H; Matsuo M; Wanaka K; Nakamoto H; Matsushima H; Sakai R Pathophysiol Haemost Thromb; 2006; 35(6):445-50. PubMed ID: 17565238 [TBL] [Abstract][Full Text] [Related]
13. Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy. Dragonetti D; Guarini G; Pizzuti M Blood Transfus; 2020 Jul; 18(4):328. PubMed ID: 32697931 [No Abstract] [Full Text] [Related]
14. Heparin-platelet factor (PF) 4 antibodies in patients with pseudothrombocytopenia: coincidence or association? Schwarzinger I; Speiser W; Lubenow N; Greinacher A; Panzer S Thromb Haemost; 2000 Dec; 84(6):1123-4. PubMed ID: 11154128 [No Abstract] [Full Text] [Related]
15. [Bilateral adrenal hemorrhage after heparin-induced thrombocytopenia, a rare cause of shock]. Reverdy F; Freichet M; Grozel JM; Tassin C; Piriou V Ann Fr Anesth Reanim; 2013 Mar; 32(3):206-7. PubMed ID: 23474000 [No Abstract] [Full Text] [Related]
17. Comparison between platelet factor 4/heparin complexes ELISA and platelet aggregation test in heparin-induced thrombocytopenia. Nguyên P; Droullé C; Potron G Thromb Haemost; 1995 Aug; 74(2):804-5. PubMed ID: 8585032 [No Abstract] [Full Text] [Related]
18. Testing for heparin-induced thrombocytopenia: are we there yet? Arnold DM; Kelton JG J Thromb Haemost; 2007 Jul; 5(7):1371-2. PubMed ID: 17439627 [No Abstract] [Full Text] [Related]
19. Measurement of heparin-dependent platelet antibodies in the diagnosis of heparin-induced thrombocytopenia: fact or fiction? Parker RI Crit Care Med; 2007 Jul; 35(7):1784-5. PubMed ID: 17581366 [No Abstract] [Full Text] [Related]
20. Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients. Schroder JN; Daneshmand MA; Villamizar NR; Petersen RP; Blue LJ; Welsby IJ; Lodge AJ; Ortel TL; Rogers JG; Milano CA Ann Thorac Surg; 2007 Sep; 84(3):841-5; discussion 845-6. PubMed ID: 17720387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]